IL6 and Parkinson disease: (31), an analysis of 84 Parkinson’s patients and 165 control samples revealed that plasma inflammation markers—including C-reactive protein, fibrinogen, tumor necrosis factor-alpha, and IL-6—are critical for predicting and diagnosing Parkinson’s disease, particularly as elevated IL-6 significantly increases the risk of developing the disease.